Drug Delivery · 2022 · 37 citations · 51 references
PharmacyOncologyPharmacologyCancer PharmacologyDrug DeliveryOral Drug DeliveryHepatobiliary CancerHepatocellular Carcinoma PharmacotherapyNanoparticle-based BioavailabilityOral NanocarriersEntrapmentHepatocellular Carcinoma TreatmentLiver Tumor TherapyOral Drug Delivery FormulationsOral Drug Delivery SystemsOral TreatmentTargeting Ligand OptimizationThin-film Hydration
nm ± 6.35, 0.229 ± 0.06, 90.56% ± 3.22, and -7.86 mV ± 1.13, respectively. LF-coated bilosomes also increased permeation of PIT when tested on Caco-2 cells by 3.1-folds (compared to uncoated ones or free PIT solution). It also improved the cytotoxicity of HepG2 spheroids 44-folds more than PIT-free solution. RT-PCR analysis showed that LF-coated PIT-loaded bilosomes caused an improvement (2-fold increase) in the apoptotic potential of PIT mediated by caspase-3. In conclusion, the optimized LF-coated PIT-loaded bilosomes were cytotoxic to HCC with improved hepatocytes permeation and cellular uptake. Thus, the proposed formula could be a promising treatment for HCC.
51
Sadek Ahmed, Mohamed A. Kassem, Sinar Sayed · International Journal of Nanomedicine · 2020 · 191 citations · Full text